* Elmera Group ASA Raised to Buy at SpareBank; PT 25 kroner
* Motorpoint Raised to Buy at Numis; PT 200 pence
* Next Raised to Buy at Numis; PT 6,800 pence
* Roche Raised to Buy at Intron Health; PT 360 Swiss francs
* Wise Raised to Add at AlphaValue/Baader
>>> Down
* Credit Suisse PT Cut to 4.40 Swiss francs at Jefferies (+)
* Hugo Boss Cut to Hold at Hauck & Aufhaeuser; PT 52 euros (+)
* Kingfisher Cut to Sell at Numis; PT 150 pence
* Maersk Cut to Hold at Nordea (+)
* Meta Platforms Cut to Neutral at Atlantic Equities; PT $160 (+)
* Scatec Cut to Neutral at SpareBank; PT 80 kroner
* TietoEVRY Cut to Hold at SEB Equities; PT 26 euros
* Vidrala Cut to Sell at Citi; PT 45 euros
* Zoom Video Cut to Equal-Weight at Morgan Stanley; PT $90
>>> Initiation
* B90 Holdings PLC Rated New Buy at Arden Partners; PT 8 pence (+)
* Bankinter Reinstated Buy at Kepler Cheuvreux; PT 7.10 euros
* Boston Beer Rated New Neutral at Wedbush; PT $350
* Brown-Forman Rated New Neutral at Wedbush; PT $70
* CaixaBank Reinstated Hold at Kepler Cheuvreux; PT 3.45 euros
* Cleantech Lithium Rated New Speculative Buy at Canaccord (+)
* Coca-Cola Rated New Outperform at Wedbush; PT $63
* Glenveagh Rated New Overweight at Barclays; PT 1.20 euros
* Instone Real Estate Rated New Underweight at Barclays
* Keurig Dr Pepper Rated New Outperform at Wedbush; PT $43
* Molson Coors Rated New Neutral at Wedbush; PT $50
* Monster Beverage Rated New Neutral at Wedbush; PT $95
* Nexity Rated New Overweight at Barclays; PT 25 euros
* NSI NV Rated New Hold at ING; PT 25 euros
* PepsiCo Rated New Outperform at Wedbush; PT $185
* Sabadell Reinstated Buy at Kepler Cheuvreux; PT 80 euro cents
* Unicaja Reinstated Hold at Kepler Cheuvreux; PT 1 euro
>>> Call
* Airbus Sept. Deliveries Encouraging, Orders Disappointing: DB (+)
* Drax, Centrica Raised at Citi With Shares Seen Reflecting Risks (+)
* Etsy Rated Buy at Goldman on Growth View, Wayfair Rated Neutral
* Goldman Sachs Says Too Early to Factor a Fed Pivot Into Markets
* Hydrogen Stocks at Cheap Entry Point After De-Rating: Jefferies (+)
* Homebuilders Facing Increasingly Tough Times, Barclays Says
* MS Cautious on Chemicals, But Sees Opportunities; Evonik Cut
* Roche Raised at Intron Health on Sector-Leading Pricing Power (+)
* Zoom Rating Cut at Morgan Stanley as Online Business Normalizes (+)